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OBJECTIVE — Diabetes guidelines recommend aggressive screening for type 2 diabetes in
Asian patients because they are considered to have a higher risk of developing diabetes and
potentially worse prognosis. We determined incidence of diabetes and risk of death or macro-
vascular complications by sex among major Asian subgroups, South Asian and Chinese, and
white patients with newly diagnosed diabetes.
RESEARCH DESIGN AND METHODS — Using population-based administrative data
from British Columbia and Alberta, Canada (1997–1998 to 2006–2007), we identiﬁed patients
with newly diagnosed diabetes aged 35 years and followed them for up to 10 years for death,
acutemyocardialinfarction,stroke,orhospitalizationforheartfailure.Ethnicitywasdetermined
using validated surname algorithms.
RESULTS — There were 15,066 South Asian, 17,754 Chinese, and 244,017 white patients
with newly diagnosed diabetes. Chinese women and men had the lowest incidence of diabetes
relativetothatofwhiteorSouthAsianpatients,whohadthehighestincidence.Mortalityinthose
withnewlydiagnoseddiabeteswaslowerinSouthAsian(hazardratio0.69[95%CI0.62–0.76],
P  0.001) and Chinese patients (0.69 [0.63–0.74], P  0.001) then in white patients. Risk of
acute myocardial infarction, stroke, or heart failure was similar or lower in the ethnic groups
relative to that of white patients and varied by sex.
CONCLUSIONS — The incidence of diagnosed diabetes varies signiﬁcantly among ethnic
groups. Mortality was substantially lower in South Asian and Chinese patients with newly
diagnosed diabetes than in white patients.
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O
ver the past 20 years, we have seen
anexplosiveincreaseinthenumber
of cases of diabetes worldwide. The
numberofindividualswithdiabetesisex-
pected to more than double by the year
2025. This will have a tremendous public
health impact given the high rates of
acute myocardial infarction [AMI],
heart failure, stroke, and death that fol-
low diabetes.
Along with advancing age and in-
creases in obesity prevalence, one puta-
tive factor thought to be contributing to
thisglobalepidemicisanescalationinthe
population of nonwhite groups at higher
risk for diabetes. The largest increases in
diabetes worldwide are occurring in de-
veloping countries. The prevalence of di-
abetes in urban areas of India is as high as
18%(1)andarecentstudyshowsathree-
fold increase in diabetes prevalence in
certain areas of China (2). South Asian
and Chinese groups may have a greater
susceptibility to developing diabetes due
to a predisposition to insulin resistance in
the presence of environmental factors in-
cluding diet and physical inactivity. Dif-
ferences in health care systems, limited
accesstohealthservices,andsocialdepri-
vation can further compound the risk of
developing diabetes and its complica-
tions.
Our current understanding of the in-
cidence and prognosis of diabetes in
South Asian and Chinese men and
women is limited. There is a paucity of
ethnicity- and sex-stratiﬁed longitudinal
population-based studies. Incidence has
only been estimated from prevalence data
in cross-sectional studies under various
health care systems. General practitioner
clinic and general population surveys in
Western countries uniformly observe a
higher prevalence of diabetes in South
Asian respondents compared with that in
the general population (3,4). Results
amongChinesemigrantsareinconsistent,
with prevalence rates up to 14% (5). Fur-
ther, it is unclear whether these groups
also have a greater susceptibility to devel-
oping complications of diabetes. We con-
ducted a large, population-based study in
two Canadian provinces to determine the
incidenceofdiabetesandtheriskofdeath
and macrovascular complications includ-
ing AMI, heart failure, and stroke among
South Asian, Chinese, and white women
and men up to 10 years after a new diag-
nosis of diabetes.
RESEARCH DESIGN AND
METHODS
Data sources
We used administrative data from two
Canadian provinces (British Columbia
1993–2006andAlberta1994–2007)that
comprise 44% of all Chinese and 34% of
all South Asian people in Canada (6).
Physicianclaimsﬁlescontaininformation
for each hospital and outpatient encoun-
ter for each patient. Hospital discharge
abstracts include all inpatient services for
all hospitals within these provinces and
contain primary and secondary discharge
diagnosiscodesoftheICD-9andICD-10,
withupto25diagnosisﬁeldsperindivid-
ual admission. Physician claims and hos-
pital discharge data are updated daily and
include all patients with provincial health
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system, virtually all residents of these
provincesarecoveredbyhealthinsurance
ensuring completeness of data. The pro-
vincial population registry contains sur-
name, birth date, sex, and postal code on
residents of the province. Population
counts from provincial registries corre-
spondtocensuspopulationestimates(7),
but, unlike census data, provide actual
counts in inter-census years. All deaths
are reported to the Vital Statistics data-
base, and date of death was obtained by
linking to Vital Statistics via a unique per-
sonal health number.
Study population
All residents of these provinces with a
physician diagnosis of diabetes were in-
cluded. Individuals with diabetes were
deﬁnedasthosewithanICD-9orICD-10
code for diabetes (ICD-9-CM: 250.x;
ICD-10: E109, E119, E139, E149, E101,
E111, E131, E141, E105, E115, E135,
and E145) for at least one hospital dis-
charge abstract or two physician claims
within 2 years. Patients aged 35 years
were excluded to reduce the misclassiﬁ-
cation of type 2 diabetes as type 1 diabe-
tes. Patients with gestational diabetes
mellitus,identiﬁedwithcodingforanob-
stetrical event within 5 months of diabe-
tes diagnosis were also excluded. This
coding algorithm was extensively vali-
dated against physician diagnosis of dia-
betes across sex, age-groups, and rural/
urban residents and among those with
and without comorbid conditions with a
sensitivity of 92.3%, speciﬁcity of 96.9%,
and a positive predictive value (PPV) of
77% (8,9).
Categorizing ethnic group
Self-reportedethnicityisnotdocumented
in administrative data in Canada. We
used validated surname analysis to cate-
gorize patients as South Asian (from Pa-
kistan, India, or Bangladesh) or Chinese
(from China, Taiwan, or Hong Kong) us-
ing surnames recorded in provincial reg-
istries. Compared with self-report, the
sensitivity for the Quan surname algo-
rithm for Chinese ethnicity was 78%,
speciﬁcity was 99.7%, and PPV was 81%
(10). For the Nam Pehchan algorithm for
South Asian ethnicity, the sensitivity was
90–94%, speciﬁcity was 99.4%, and PPV
was 63–96% (11–13). All remaining pa-
tients are referred to as “white” because this
group is largely (93.2%) composed of
white, nonvisible minority individuals (6).
Procedures
To determine incident cases, we identi-
ﬁed all patients in whom diabetes was di-
agnosed at each ﬁscal year. Patients with
incident cases had a minimum of 3 previ-
ous years without any coding for diabetes
in hospital or physicians claims ﬁles to
minimize misclassifying prevalent cases
asincident(98.9%ofpatientsineacheth-
nic group still had nondiabetes physician
visits in this time period). Thus, incident
cases are determined for 1997–2003. To
avoid falsely attributing the absence of
diabetes diagnosis to newly arrived im-
migrants, we only included those pa-
tients with health insurance registration
for at least 3 years before their diabetes
diagnosis.
To control for severity of illness at the
time of diagnosis of diabetes, we mea-
sured clinical variables from the Charlson
Comorbidity Index validated to predict
mortality in patients with type 2 diabetes
(14). Socioeconomic status (SES) was as-
sessed using area level median income
based on the patient’s postal code. SES
data were missing for 11,665 patients
(2.5% Chinese, 2.9% South Asian, and
4.4% white). A missing value was as-
signedtothesepatientsandretainedinall
models.
Outcomes
Timetodeathafterdiabetesdiagnosiswas
the primary outcome. Secondary out-
comes included hospitalization for AMI,
acute stroke, or heart failure and were de-
termined using validated coding algo-
rithms in hospital discharge abstracts:
AMI (ICD-9 410; ICD-10 I21), PPV 0.95
(15); stroke (ICD-9 430, 431, 434, and
436; ICD-10 I60-I62, I63.3-I63.5, I63.8,
I63.9, and I64), PPV 0.85–0.98 (16); and
heart failure (ICD-9 428.x; ICD-10 I5O),
PPV0.84(17).Timetoeventwasassessed
upto31March2006forBritishColumbia
andto31March2007forAlbertawithup
to 10 years follow-up (median 4.0 years).
Patients were censored if they moved out
of the province or reached the end of the
observation period.
Statistical analysis
We determined age-speciﬁc (reported for
the most recent ﬁscal year, 2003–2004)
and age-standardized incidence of diag-
nosed diabetes for each ethnic and sex
group. Yearly incidence of diagnosed di-
abetes (per 1,000 population) was calcu-
lated using new cases of diabetes for each
group as the numerator with the corre-
sponding population count as the de-
nominatorforthemostrecent5-yeartime
period (1999–2003). Annual population
countsforeachethnicandsexgroupwere
determined by applying the surname al-
gorithms to the annual provincial registry
population counts, minimizing denomi-
nator bias. We used direct age standard-
ization for each group with the total
provincial population in the same ﬁscal
year as the reference group. Poisson re-
gression analysis was used to compare in-
cidence rates between ethnic and sex
groups and linear regression was used to
determine change in incidence over time.
Categorical variables were compared
using the 
2 test. Cox proportional haz-
ards models were constructed and strati-
ﬁed by sex, with adjustment for province,
SESquintile,agein5-yearcategories,pre-
vious history of AMI, heart failure, cere-
brovascular disease, peripheral arterial
disease, renal impairment, cancer, de-
mentia, chronic pulmonary disease, hy-
pertension, rheumatic disease, peptic
ulcer disease, liver disease, hemiplegia,
metastatic carcinoma, and AIDS/HIV. We
also conducted sensitivity analyses using
the British Columbia cohort by addition-
ally adjusting for insulin, metformin, sta-
tin, or ACE inhibitor prescribing within 5
years of diagnosis using a province-wide
prescription drug database (PharmaNet)
only available in British Columbia.
AllanalyseswereconductedwithSAS
(version 9.1.3) and graphs were plotted
using R. This study was approved by the
local ethics institutional review boards.
RESULTS— There were 555,206 pa-
tients who met the coding deﬁnition for
diabetes. After exclusion of 18,037 pa-
tients aged 35 years, 17,602 with gesta-
tional diabetes, 199,592 patients without
a minimum 3-year period of observation
without a diabetes diagnosis, and 43,138
patients without insurance registration
within 3 years before diabetes diagnosis,
276,837 remaining patients were identi-
ﬁed as having incident cases of diagnosed
diabetes (15,066 [5.4%] South Asian,
17,754 [6.4%] Chinese, and 244,017
[88.1%] white patients).
South Asian patients were 4.6 years
younger on average than Chinese and
white patients at diagnosis of diabetes
(Table1).Whitepatientsweremorelikely
to have cardiovascular disease and cancer
relative to the ethnic groups.
Diabetes incidence
From Table 2, incidence of diagnosed
diabetes was higher among men relative
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South Asian patients had the highest
age-adjusted incidence of diabetes,
whereas Chinese patients had the low-
est (Fig. 1). In the age-speciﬁc inci-
dence, South Asian patients had the
highest incidence of diabetes in all
young to middle-aged categories. How-
ever,aftertheageof65,theincidenceof
diabetes was highest among white pa-
tients. Diabetes incidence for white pa-
tients and Chinese men increased
during the observation period but re-
mained stable for South Asian patients
and Chinese women (Fig. 1).
Mortality and macrovascular
complications
Total mortality was substantially lower in
South Asian and Chinese men and
women than in white men and women
(Table 3). Even after adjustment for base-
line characteristics, mortality remained
substantially lower in South Asian and
Chinese patients. Additional adjustment
for use of insulin, metformin, ACE inhib-
itors, or statin therapy in the sensitivity
analysis did not materially affect these re-
sults. These differences were seen across
different age subgroups, within each
province, and among those with and
without comorbid conditions.
Macrovascular complications among
ethnic groups varied by sex. South Asian
and white women had a similar risk of
developingmacrovascularcomplications.
However, Chinese women had a substan-
tially lower risk of AMI and heart failure.
SouthAsianandChinesemenhadalower
risk of stroke and heart failure relative to
that of white men. Chinese men had the
lowest risk for AMI whereas South Asian
and white men had a similar risk of AMI.
CONCLUSIONS — South Asian pa-
tients had the highest incidence of diag-
nosed diabetes, whereas Chinese patients
had the lowest incidence. Mortality was
also lower for South Asian and Chinese
patients compared with that for white pa-
tients with newly diagnosed diabetes, for
both men and women. However, macro-
vascular complications varied by ethnic-
ity and sex.
There is a disproportionately high
rateofnewcasesofdiabetesamongyoung
to middle-aged, South Asian patients.
Our ﬁndings afﬁrm estimates from nu-
merousprevalencestudies(3,4).Theage-
Table 1—Baseline characteristics among diabetic patients aged >35 years
Characteristics Chinese South Asian White P value
n 17,754 15,066 244,017
Age at diagnosis
Age (years) 59.7  12.8 56.5  12.3 61.3  13.1 0.001
35–49 years 4,390 (24.7) 4,753 (31.6) 50,082 (20.5) 0.001
50–64 years 6,680 (37.6) 6,307 (41.9) 94,788 (38.8)
65–79 years 5,507 (31.0) 3,424 (22.7) 76,717 (31.4)
80 years 1,177 (6.6) 582 (3.9) 22,430 (9.2)
Female sex 8,458 (47.6) 6,672 (44.3) 110,142 (45.1) 0.001
Province: British Columbia 14,084 (79.3) 9,529 (63.3) 143,630 (58.9) 0.001
Socioeconomic quintile
First quintile (low) 4,370 (24.6) 3,208 (21.3) 56,915 (23.3) 0.001
Second quintile 3,908 (22.0) 3,498 (23.2) 49,138 (20.1)
Third quintile 2,990 (16.8) 3,051 (20.3) 46,377 (19.0)
Fourth quintile 2,814 (15.9) 2,730 (18.1) 42,607 (17.5)
Fifth quintile (high) 3,223 (18.2) 2,147 (14.3) 38,196 (15.7)
Unknown 449 (2.5) 432 (2.9) 10,784 (4.4)
Comorbid conditions
Hypertension 7,308 (41.2) 5,612 (37.3) 99,578 (40.8) 0.001
Myocardial infarction 266 (1.5) 473 (3.1) 10,152 (4.2) 0.001
Congestive heart failure 444 (2.5) 498 (3.3) 14,578 (6.0) 0.001
Peripheral vascular disease 245 (1.4) 155 (1.0) 6,234 (2.6) 0.001
Cerebrovascular disease 447 (2.5) 358 (2.4) 9,318 (3.8) 0.001
Dementia 121 (0.7) 106 (0.7) 4,103 (1.7) 0.001
Chronic pulmonary disease 1,394 (7.9) 1,794 (11.9) 31,032 (12.7) 0.001
Renal disease 324 (1.8) 194 (1.3) 5,090 (2.1) 0.001
Cancer 593 (3.3) 372 (2.5) 14,127 (5.8) 0.001
Oral hypoglycemic agent* 4,619 (32.8) 3,731 (39.1) 52,590 (36.6) 0.001
Insulin* 149 (1.1) 130 (1.36) 4,092 (2.85) 0.001
Data are means  SD or n (%). *Medication prescribed within 1 year of diagnosis in British Columbia
patients only.
Table 2—Age-speciﬁc incidence of diagnosed diabetes by ethnicity and sex (per 1,000 population) in ﬁscal year 2003–2004
Age
Chinese South Asian White
New
cases Pop*
Incidence
(95% CI) P value
New
cases Pop*
Incidence
(95% CI) P value
New
cases Pop
Incidence
(95% CI)
Women
35–44 years 128 61,099 2.1 (1.7–2.5) 0.006 129 27,846 4.6 (3.8–5.4) 0.001 1,367 506,420 2.7 (2.6–2.8)
45–54 years 292 50,900 5.7 (5.1–6.4) 0.99 205 22,069 9.3 (8.0–10.6) 0.001 2,757 480,861 5.7 (5.5–6.0)
55–64 years 214 23,479 9.1 (7.9–10.3) 0.04 257 16,795 15.3 (13.5–17.2) 0.001 3,424 323,964 10.6 (10.2–10.9)
65 years 464 40,374 11.5 (10.5–12.5) 0.004 240 19,257 12.5 (10.9–14.0) 0.4 5,787 438,246 13.2 (12.9–13.5)
Men
35–44 years 154 53,886 2.9 (2.4–3.3) 0.1 257 30,600 8.4 (7.4–9.4) 0.001 1,622 502,421 3.2 (3.1–3.4)
45–54 years 339 50,521 6.7 (6.0–7.4) 0.02 277 22,760 12.2 (10.8–13.6) 0.001 3,704 482,218 7.7 (7.4–7.9)
55–64 years 290 23,681 12.3 (10.9–13.7) 0.02 288 16,709 17.2 (15.3–19.2) 0.001 4,572 324,698 14.1 (13.7–14.5)
65 years 411 35,126 11.7 (10.6–12.8) 0.001 228 17,768 12.8 (11.2–14.5) 0.001 5,940 354,004 16.8 (16.4–17.2)
*2003–2004 population.
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diabetesamongwhitepatientsisalsocon-
sistent with general population incidence
rates(8).Theobservedlowerincidenceof
diabetes in Chinese patients contrasts
with that in a small study reporting a sim-
ilar incidence between Chinese and other
patients in the U.S.; however, age-
adjusted incidence was not determined
(18).
Diabetes guidelines generally recom-
mend initial screening for diabetes at age
45 years, although a younger threshold is
recommended for patients of Asian de-
scent. The optimal age at which to start
early surveillance in South Asians is un-
clear. It is also not known whether early
surveillance would beneﬁt other Asian
groups (e.g., Chinese). This study identi-
ﬁed an alarmingly high incidence of dia-
betes in South Asian patients, particularly
in men aged 35–44 years, indicating that
screening as early as 35 years may be
warranted. Our ﬁndings also suggest
that Chinese patients do not necessarily
share this early proclivity for develop-
ing diabetes.
Despite a greater predilection for de-
veloping diabetes, we found a paradoxi-
cally lower mortality among South Asians
than among white patients. Chinese pa-
tients also had a signiﬁcantly lower mor-
tality. Although South Asian patients
were considerably younger and both
South Asian and Chinese patients pos-
sessed fewer comorbid conditions at the
onset of diabetes, the mortality beneﬁt
persistedafteradjustmentforthesediffer-
ences. Our ﬁndings are consistent with
results from several smaller studies of di-
abetic patients (19,20), and general pop-
ulation mortality rates also indicate lower
all-cause mortality for South Asian and
Chinese patients compared with white
patients living in North America (21).
Our results, however, contrast with those
for the Southall Diabetes Survey cohort,
which reported a nonsigniﬁcant trend to-
ward increased mortality in South Asian
patients compared with their white coun-
terparts using prevalent rather than inci-
dent cases (22). However, mortality rates
for all groups were substantially higher
compared with general population mor-
tality rates for Chinese, South Asian, and
white patients living in North America
(21). This observation suggests that the
presence of diabetes confers a greater risk
of death regardless of ethnicity.
Thereasonsfortheethnicandsexdif-
ferences in mortality and macrovascular
complicationsofdiabetesareunclear,and
Figure1—A:Age-adjustedincidenceofdiagnoseddiabetesbyethnicityinwomenaged35years
(1999–2003). B: Age-adjusted incidence of diagnosed diabetes by ethnicity in men aged 35
years. Œ, South Asian; E, white; F, Chinese.
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nisms. South Asian and Chinese patients,
particularly men, may have their diabetes
diagnosed earlier along the course of dis-
ease and may receive more aggressive
care. However, even after we adjusted for
metformin,statin,andACEinhibitorpre-
scribing, the mortality beneﬁt in South
Asian and Chinese patients persisted. Al-
ternatively, some ethnic patients may not
have accessed medical care and were
therefore not included in the study pop-
ulation. These individuals with undiag-
nosed diabetes may be more likely to
experience early mortality. However, a
national survey in Canada found that vis-
ible minority and white patients reported
a similarly high frequency of physician
visits (23). Chinese and South Asian pa-
tients have lower rates of smoking and
BMI,potentiallycontributingtotheirsur-
vival advantage. However, these differ-
ences are unlikely to account for all the
beneﬁt. In a U.S. study, despite adjust-
ment for these differences, a lower risk of
AMI, stroke, and heart failure was identi-
ﬁed in Asian patients with newly diag-
nosed diabetes (24); however, South
Asian and Chinese subgroups were not
analyzedseparately.Inouranalysis,white
patients had higher rates of cardiovascu-
lar complications and therefore may have
higherratesofcardiovasculardeath.Con-
sistent with a general population study,
white patients may also have higher rates
of noncardiovascular death, including
deaths due to cancer (21), collectively
contributing to their higher all-cause
mortality.Ethnicdifferencesinmacrovas-
cular complications were largely attenu-
ated in women. This observation may
reﬂect fewer differences in diabetes man-
agement among women of different eth-
nic backgrounds. A study of 9,833
diabetic patients identiﬁed similar service
delivery and intermediate outcomes in-
cluding A1C levels and systolic blood
pressure among Scottish and South Asian
women (25). The lower rates of cardio-
vascular complications in the ethnic
groups may reﬂect possible differences in
chronic disease management including
increased adherence to medication and
strong family supports. Some of these in-
ﬂuences such as family support and care-
giving may also differ by sex within
cultural groups.
The strengths of this study include
the use of population-based data for a
large,ethnicallydiverseareausingcoding
algorithms extensively validated against
physician diagnosis in the same geo-
graphic region. However, there are sev-
eral limitations. First, we used surname
algorithms alone to categorize ethnicity
rather than self-report. Although the
speciﬁcities of these algorithms were
high, there is potential for some misclas-
siﬁcation of ethnic categories that would
underestimate differences among ethnic
categories.Second,wecouldnotdifferen-
tiate type 1 and type 2 diabetes, although
fromoursensitivityanalysisinBritishCo-
lumbia, 3% of patients received insulin
within1yearofdiabetesdiagnosis.Third,
we were only able to identify physician-
diagnosed diabetes, underestimating the
true incidence of diabetes. Fourth, obser-
vational studies are susceptible to bias
from residual confounding including
confounding by age. There may be resid-
ual confounding by age. We were unable
to control for differences in smoking,
BMI,visceralfat,anddiabetescontrol.We
did not have information on year of im-
migration,butbecausethemajorityofim-
migration to Canada by these ethnic
groups has occurred in the past 25 years
(6), this population would largely be
composed of ﬁrst-generation immigrants.
Finally, we used broad ethnic categories,
and there is likely some heterogeneity
among smaller subgroups within each
ethnic category.
Insummary,diabetesincidenceand
outcomes are heavily inﬂuenced by eth-
nicity and sex. South Asian patients
have a signiﬁcantly higher incidence of
physician-diagnosed diabetes that is
concentrated at young and middle ages,
whereas Chinese patients do not. These
results may have implications for
screening and timing of culturally sen-
sitive interventions to reduce this epi-
demic. We also observed a paradoxical
ﬁnding that despite a high incidence of
diabetes, mortality was lower in South
Asian patients than in the general dia-
betic population and macrovascular
complication occurrence further varied
by sex. Mortality was similarly low in
Chinese patients. Further studies are
neededtoconﬁrmthisparadoxicalﬁnd-
ing and elucidate underlying mecha-
nisms for differences in diabetes risk
and outcomes by ethnicity and sex.
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Table 3—Age-standardized and -adjusted outcomes by ethnicity in diabetic women and men
aged >35 years
Outcome
Age standardized events/1,000
patient years Hazard ratio (95% CI),* P value
Chinese South Asian White Chinese vs. white South Asian vs. white
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n 8,458 6,672 110,142
Mortality 18.6 20.7 30.9 0.69 (0.63–0.74)
P  0.001
0.69 (0.62–0.76)
P  0.001
Stroke 4.1 5.3 4.7 0.91 (0.76–1.08)
P  0.26
1.06 (0.88–1.29)
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0.95 (0.79–1.15)
P  0.6
Men
n 9,296 8,394 133,875
Mortality 17.8 20.5 32.6 0.61 (0.60–0.66)
P  0.001
0.68 (0.63–0.74)
P  0.001
Stroke 4.2 4.3 5.1 0.81 (0.69–0.96)
P  0.01
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P  0.001
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P  0.49
Heart failure 2.0 4.4 6.4 0.38 (0.30–0.48)
P  0.01
0.71 (0.56–0.92)
P  0.01
*Hazard ratios are adjusted for age, SES, province, and comorbid conditions including previous history of
AMI, heart failure, cerebrovascular disease, peripheral arterial disease, renal impairment, cancer, dementia,
chronic pulmonary disease, hypertension, connective tissue disease-rheumatic disease, peptic ulcer disease,
mild liver disease, paraplegia and hemiplegia, moderate or severe liver disease, metastatic carcinoma, and
AIDS/HIV.
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